Tower Research Capital LLC (Trc) Theravance Biopharma, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $5.8 Billion
- Q2 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 9,789 shares of TBPH stock, worth $79,290. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,789
Previous 398
2359.55%
Holding current value
$79,290
Previous $3,000
2666.67%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding TBPH
# of Institutions
134Shares Held
48.7MCall Options Held
13.9KPut Options Held
3.1K-
Madison Avenue Partners, LP New York, NY8.51MShares$68.9 Million12.2% of portfolio
-
Weiss Asset Management LP Boston, MA7.46MShares$60.4 Million3.74% of portfolio
-
Seth Klarman Baupost Group LLC | Boston, Ma4.2MShares$34 Million0.98% of portfolio
-
Black Rock Inc. New York, NY3.78MShares$30.6 Million0.0% of portfolio
-
Irenic Capital Management LP New York, NY2.76MShares$22.4 Million2.86% of portfolio
About Theravance Biopharma, Inc.
- Ticker TBPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,782,400
- Market Cap $541M
- Description
- Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...